Journal Information
Vol. 14. Issue 2.
Pages 170-174 (March - April 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 2.
Pages 170-174 (March - April 2010)
Original Article
Open Access
BKV-infection in kidney graft dysfunction
Visits
2643
Juliana Montagner1,2,
Corresponding author
jmontagner@mixmail.com

Correspondence to: Rua Coronel Corte Real 311/702 – Petrópolis Porto Alegre – RS – Brazil CEP: 90630-080.
, Tatiana Michelon1,2, Barbara Fontanelle1, Alexandre Oliveira1, Janaina Silveira1,2, Regina Schroeder1,2, Jorge Neumann2, Elizete Keitel1, Claudio Osmar Pereira Alexandre1
1 Post-Graduation in Pathology – Universidade Federal de Ciências da Saúde de Porto Alegre
2 Transplant Immunology Laboratory - Santa Casa de Porto Alegre Hospital, RS, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Introduction

BKV nephropathy (BKN) causes kidney graft loss, whose specific diagnosis is invasive and might be predicted by the early detection of active viral infection.

Objective

Determine the BKV-infection prevalence in late kidney graft dysfunction by urinary decoy cell (DC) and viral DNA detection in urine (viruria) and blood (viremia; active infection).

Methods

Kidney recipients with >1 month follow-up and creatinine >1.5mg/dL and/or recent increasing >20% (n=120) had their urine and blood tested for BKV by semi-nested PCR, DC searching, and graft biopsy. PCR-positive patients were classified as 1+, 2+, 3+. DC, viruria and viremia prevalence, sensitivity, specificity, and likelihood ratio (LR) were determined (Table 2×2). Diagnosis efficacy of DC and viruria were compared to viremia.

Results

DC prevalence was 25%, viruria 61.7%, and viremia 42.5%. Positive and negative patients in each test had similar clinical, immunossupressive, and histopathological characteristics. There was no case of viremia with chronic allograft nephropathy and, under treatment with sirolimus, patients had a lower viruria prevalence (p=0.043). Intense viruria was the single predictive test for active infection (3+; LR = 2.8).1,6-4,9

Conclusion

DC, BKV-viruria and -viremia are commun findings under late kidney graft dysfunction. Viremia could only be predicted by intense viruria. These results should be considered under the context of BKN confirmation.

Keywords:
BK virus
decoy cells
kidney transplantation
PCR
viremia
viruria
Full text is only aviable in PDF
References
[1.]
I. Agha, D.C. Brennan.
BK virus and immunosuppressive agents.
Adv Exp Med Biol, 577 (2006), pp. 174
[2.]
A.J. Duclos, V. Krishnamurthi, M. Lard, et al.
Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.
Transplant Proc, 38 (2006), pp. 3666
[3.]
A. Behzad-Behbahani, P.E. Klapper, P.J. Valley, G.M. Cleator, S.H. Khoo.
Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation.
J Clin Virol, 29 (2004), pp. 224
[4.]
T. Takayama, K. Miura, G. Han, T. Ushiyama, K. Suzuki, K. Fujita.
Bk virus subtype 1 infection associated with tubulointerstitial nephritis in a renal allograft recipient.
[5.]
R. Boldorini, M. Brustia, C. Veggiani, D. Barco, S. Andorno, G. Monga.
Periodic Assessment of urine and serum by cytology and molecular biology as a diagnostic tool for BK vírus nephropathy in renal transplant patients.
Acta Cytol, 49 (2005), pp. 235
[6.]
A.L. McNees, Z.S. White, P. Zanwar, R.A. Vilchez, J.S. Butel.
Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR.
J Clin Virol, 34 (2005), pp. 52
[7.]
G. Gupta, R. Shapiro, N. Thai, P.S. Randhawa, A. Vats.
Low incidence of BK virus nephropathy after simultaneous kidney pancreas transplantation.
Transplantation, 82 (2006), pp. 382
[8.]
P.S. Randhawa, S. Finkelstein, V. Scantlebury, et al.
Human polyoma virus-associated interstitial nephritis in the allograft kidney.
Transplantation, 67 (1999), pp. 103
[9.]
R. Ding, M. Medeiros, D. Dadhania, et al.
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine.
Transplantation, 74 (2002), pp. 987
[10.]
A. Vats, P.S. Randhawa, R. Shapiro.
Diagnosis and treatment of BK virus-associated transplant nephropathy.
Adv Exp Med Biol, 577 (2006), pp. 213
[11.]
P. Liptak, E. Kemeny, B. Ivanyi.
Primer: histopathology of polyomavirus-associated nephropathy in renal allografts.
Nat Clin Pract Nephrol, 2 (2006), pp. 631
[12.]
E. Ramos, H.H. Hirsch.
Polyomavirus-associated nephropathy: updates on a persisting challenge.
Transpl Infect Dis, 8 (2006), pp. 59
[13.]
V. Nickeleit, H.H. Hirsch, I.F. Binet, et al.
Polyomavirus infection of renal allograft recipients.
J Am Soc Nephrol, 10 (1999), pp. 1080
[14.]
C.Y. Tong, R. Hilton, E.M.E. MacMahon, et al.
Monitoring the progress of BK virus associated nephropathy in renal transplant recipients.
Nephrol Dial Transplant, 19 (2004), pp. 2598
[15.]
C.B. Drachenberg, H.H. Hirsch, E. Ramos, J.C. Papadimitriou.
Polyomavirus disease in renal transplantation review of pathological findings and diagnostic methods.
[16.]
A. Si-Mohamed, J.L. Goff, N. Désiré, S. Maylin, D. Glotz, L. Bélec.
Detection and quantification of BK virus DNA by real-time polymerase chain reaction in the LT-Ag gene in adult renal transplant recipients.
J Virol Methods, 131 (2006), pp. 21
[17.]
L.C. Racusen, K. Solez, R.B. Colvin, et al.
The Banff 97 working classification of renal allograft pathology.
Kidney Int, 55 (1999), pp. 713-723
[18.]
D.R.J. Kuypers, A.K. Vandooren, E. Lerut, et al.
Adjuvant Low-dose Cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
Am J Transplant, 5 (2005), pp. 1997
[19.]
S. Hariharan.
BK virus nephritis after renal transplantation.
Kidney Int, 69 (2006), pp. 655
[20.]
G. Zavos, M. Gazouli, E. Psimenou, et al.
Polyomavirus BK infection in Greek transplant recipients.
Transplant Proc, 36 (2004), pp. 1413
[21.]
K.W. Lee, H.H. Lee, D.S. Lee, et al.
Polimerase chain reaction for the diagnosis of human Polyomavirus-associated nephropathy in renal transplant recipients.
Transplant Proc, 36 (2004), pp. 2116
[22.]
C.B. Drachenberg, J.C. Papadimitriou, H.H. Hirsch, et al.
Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load.
Am J Transplant, 4 (2004), pp. 2082
[23.]
F. Ginevri, A. Azzi, H.H. Hirsch, et al.
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients.
Am J Transplant, 7 (2007), pp. 2727
[24.]
H.H. Hirsch, W. Knowles, M. Dickenmann, et al.
Prospective study of Polyomavirus type BK replication and nephropathy in renal-transplant recipients.
N Engl J Med, 347 (2002), pp. 488
[25.]
B.C. Bodin, M.C. Burel, M. Hourmant, V. Sebille, E.A. Garnier, B.M.I. Marcille.
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients.
Am J Transpl, 5 (2005), pp. 1926
[26.]
M. Fogeda, P. Munõs, A. Luque, M.D. Morales, E. Bouza.
Cross-sectional of BK virus infection in pediatric kidney transplant recipients.
Pediatr Transplant, 11 (2007), pp. 394
[27.]
F. Ginevri, R. Santis, P. Comoli, et al.
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches.
Transplantation, 75 (2003), pp. 1266
[28.]
L. Hayson, A.R. Rosenberg, G. Kainer, et al.
BK viral infection in an Autralian pediatric renal transplant population.
Pediatric Transplant, 8 (2004), pp. 480
[29.]
P.N. Rocha, T.J. Plumb, S.E. Miller, D.N. Howell, S.R. Smith.
Risk factors for BK polyomavirus nephritis in renal allograft recipients.
Clin Transpl, 18 (2004), pp. 456
[30.]
K.R. Wali, C. Drachenberg, H.H. Hirsch, et al.
BK Virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression.
Transplantation, 78 (2004), pp. 1069
[31.]
C.A. Benavides, V.B. Pollard, S. Mauiyyedi, H. Podder, R. Knight, B.D. Kahan.
BK-virus-associated nephropathy in sirolimustreated renal transplant patients: incidence, course, and clinical outcomes.
[32.]
P. Randhawa, R. Shapiro, A. Vats.
Quantitation of DNA of Polyomaviruses BK and JC in Human Kidneys.
Journal Infect Dis, 192 (2005), pp. 504
[33.]
K. Kapila, M.R. Nampoory, K.V. Johny, et al.
Role of urinary cytology in detecting human polyoma BK virus in kidney transplant recipients. A preliminary report.
Med Princ Pract, 16 (2007), pp. 237
[34.]
K. Marinelli, P. Bagnarelli, G. Gaffi, et al.
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients.
New Microbiol, 30 (2007), pp. 275
[35.]
R.R. Arthur, S. Dagostin, K.V. Shah.
Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.
J Clin Microbiol, 27 (1989), pp. 1174
[36.]
F.J. Vera-Sempere, L. Rubio, M.J. Moreno-Baylach, et al.
Polymerase Chain Reaction detection of BK virus and monitoring of BK nephropathy in renal transplant recipients at the University Hospital La Fe.
Transplant Proc, 37 (2005), pp. 3777
[37.]
C.B. Drachenberg, H.H. Hirsch, J.C. Papadimitriou, et al.
Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
Transplantation, 84 (2007), pp. 323
[38.]
P.D. Ling, J.A. Lednicky, W.A. Keitel, et al.
The dynamics of herpes-virus and polyomavirus reactivation and shedding in healthy adults: a 14-months longitudinal study.
J Infect Dis, 187 (2003), pp. 1571
[39.]
L. Jin, V. Pietropaolo, J.C. Booth, K.H. Ward, D.W. Brown.
Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis.
Clin Diagn Virol, 3 (1995), pp. 285
[40.]
A. Dolei, V. Pietropaolo, E. Gomes, et al.
Polyomavirus persistence in lyphocytes from blood donors and healthy personnel of a blood transfusion centre.
J Gen Virol, 81 (2000), pp. 1967
[41.]
K. Dorries, E. Vogel, S. Gunther, S. Czub.
Infection of human polyomaviruses JC and BK in peripheral blood leukocyte from immunocompetent individuals.
Virology, 198 (1994), pp. 59
[42.]
M.D. Reploeg, G.A. Storch, D.B. Clifford.
BK virus: a clinical review.
Clin Inf Dis, 33 (2001), pp. 191
[43.]
H.B. Viscount, A.J. Eid, M.J. Espy, et al.
Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.
Transplantation, 84 (2007), pp. 340
[44.]
G.A. Funk, J. Steiger, H.H. Hirsch.
Rapid dynamics of polyomavirus type BK in renal transplant recipients.
J Infect Dis, 193 (2006), pp. 80
[45.]
L.C. Hymes, B.L. Warshaw.
Polyomavirus (BKV) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis.
Pediatr Transplantation, 10 (2006), pp. 920
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools